These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 22226489

  • 21. Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease.
    Polito C, Berti V, Ramat S, Vanzi E, De Cristofaro MT, Pellicanò G, Mungai F, Marini P, Formiconi AR, Sorbi S, Pupi A.
    Neurobiol Aging; 2012 Jan; 33(1):206.e29-39. PubMed ID: 20961661
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients.
    Dujardin K, Defebvre L, Duhamel A, Lecouffe P, Rogelet P, Steinling M, Destée A.
    J Neurol; 2004 Nov; 251(11):1383-92. PubMed ID: 15592735
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P.
    Kawai Y, Suenaga M, Takeda A, Ito M, Watanabe H, Tanaka F, Kato K, Fukatsu H, Naganawa S, Kato T, Ito K, Sobue G.
    Neurology; 2008 Apr 15; 70(16 Pt 2):1390-6. PubMed ID: 18413566
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cognitive functions in Parkinson's disease: relation to disease severity and hallucination.
    Wakamori T, Agari T, Yasuhara T, Kameda M, Kondo A, Shinko A, Sasada S, Sasaki T, Furuta T, Date I.
    Parkinsonism Relat Disord; 2014 Apr 15; 20(4):415-20. PubMed ID: 24467818
    [Abstract] [Full Text] [Related]

  • 32. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
    Weng YH, Yen TC, Chen MC, Kao PF, Tzen KY, Chen RS, Wey SP, Ting G, Lu CS.
    J Nucl Med; 2004 Mar 15; 45(3):393-401. PubMed ID: 15001678
    [Abstract] [Full Text] [Related]

  • 33. Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease.
    Zeighami Y, Fereshtehnejad SM, Dadar M, Collins DL, Postuma RB, Dagher A.
    Neuroimage Clin; 2019 Mar 15; 24():101986. PubMed ID: 31514113
    [Abstract] [Full Text] [Related]

  • 34. Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease.
    Müller U, Wächter T, Barthel H, Reuter M, von Cramon DY.
    J Neural Transm (Vienna); 2000 Mar 15; 107(3):303-19. PubMed ID: 10821439
    [Abstract] [Full Text] [Related]

  • 35. Assessing dopaminergic function in Parkinson's disease: levodopa kinetic-dynamic modeling and SPECT.
    Contin M, Martinelli P, Riva R, Dondi M, Fanti S, Pettinato C, Scaglione C, Albani F, Baruzzi A.
    J Neurol; 2003 Dec 15; 250(12):1475-81. PubMed ID: 14673582
    [Abstract] [Full Text] [Related]

  • 36. Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.
    Liepelt I, Reimold M, Maetzler W, Godau J, Reischl G, Gaenslen A, Herbst H, Berg D.
    Mov Disord; 2009 Jul 30; 24(10):1504-11. PubMed ID: 19489069
    [Abstract] [Full Text] [Related]

  • 37. Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT.
    Pöpperl G, Tatsch K, Ruzicka E, Storch A, Gasser T, Schwarz J.
    J Neural Transm (Vienna); 2004 Aug 30; 111(8):1041-52. PubMed ID: 15254792
    [Abstract] [Full Text] [Related]

  • 38. Estimation of further disease progression of Parkinson's disease by dopamin transporter scan vs clinical rating.
    Vogt T, Kramer K, Gartenschlaeger M, Schreckenberger M.
    Parkinsonism Relat Disord; 2011 Jul 30; 17(6):459-63. PubMed ID: 21515087
    [Abstract] [Full Text] [Related]

  • 39. Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease.
    Liu RS, Lin KN, Wang SJ, Shan DE, Fuh JL, Yeh SH, Liu HC.
    Nucl Med Commun; 1992 Oct 30; 13(10):744-8. PubMed ID: 1491839
    [Abstract] [Full Text] [Related]

  • 40. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.
    Rektorova I, Srovnalova H, Kubikova R, Prasek J.
    Mov Disord; 2008 Aug 15; 23(11):1580-7. PubMed ID: 18618663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.